Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:17931663rdf:typepubmed:Citationlld:pubmed
pubmed-article:17931663lifeskim:mentionsumls-concept:C0010453lld:lifeskim
pubmed-article:17931663lifeskim:mentionsumls-concept:C0040704lld:lifeskim
pubmed-article:17931663lifeskim:mentionsumls-concept:C0687129lld:lifeskim
pubmed-article:17931663lifeskim:mentionsumls-concept:C0225336lld:lifeskim
pubmed-article:17931663lifeskim:mentionsumls-concept:C0253930lld:lifeskim
pubmed-article:17931663lifeskim:mentionsumls-concept:C1704632lld:lifeskim
pubmed-article:17931663lifeskim:mentionsumls-concept:C0871261lld:lifeskim
pubmed-article:17931663lifeskim:mentionsumls-concept:C2911692lld:lifeskim
pubmed-article:17931663lifeskim:mentionsumls-concept:C1706817lld:lifeskim
pubmed-article:17931663lifeskim:mentionsumls-concept:C0596235lld:lifeskim
pubmed-article:17931663lifeskim:mentionsumls-concept:C0596578lld:lifeskim
pubmed-article:17931663lifeskim:mentionsumls-concept:C1709059lld:lifeskim
pubmed-article:17931663pubmed:issue19-20lld:pubmed
pubmed-article:17931663pubmed:dateCreated2007-11-5lld:pubmed
pubmed-article:17931663pubmed:abstractTextIn order to determine whether integrin dynamics is associated with intracellular Ca(2+) concentration ([Ca(2+)](i)) mobilization in ECs in response to hemodynamic forces, changes in [Ca(2+)](i) in fluo-4-loaded cultured bovine aortic endothelial cells (BAECs) under fluid flow conditions were visualized employing laser scanning confocal microscopy. Following the onset of flow stimulus, transient increases in [Ca(2+)](i) occurred several times in individual BAECs during the 30-min observation period. The frequency of these [Ca(2+)](i) transients was clearly reduced by the application of an integrin antagonist (GRGDSP peptide). Furthermore, treatment of cells with an integrin activator (Mn(2+)) resulted in reduction of peak [Ca(2+)](i) levels and elevated frequency, which was markedly rescued upon GRGDSP administration. In contrast, an actin de-polymerizing agent (cytochalasin D) exerted no inhibitory effects; rather, cytochalasin D more likely facilitated [Ca(2+)](i) transients. Moreover, [Ca(2+)](i) transients, which were suppressed by short interference RNA-induced silencing of alphav integrin, exhibited greater frequently in cells cultured on vitronectin substratum in comparison with those cultured on fibronectin or collagen substratum. Either removal of extracellular Ca(2+), application of an inhibitor of endoplasmic reticulum Ca(2+)-ATPase (thapsigargin) or non-selective cation channel blocker (La(3+)) inhibited the [Ca(2+)](i) transients. Additionally, [Ca(2+)](i) transients were attenuated by extracellular signal-regulated kinase (ERK) kinase inhibitor (U0126); in contrast, [Ca(2+)](i) transients were unaffected by tyrosine kinase inhibitor (genistein) or phosphatidylinositol 3-kinase (PI3K) inhibitor (LY294002). Therefore, our findings revealed that alphav integrin dynamics modulates the frequency of flow-induced [Ca(2+)](i) transients in BAECs in an ERK-dependent fashion.lld:pubmed
pubmed-article:17931663pubmed:languageenglld:pubmed
pubmed-article:17931663pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17931663pubmed:citationSubsetIMlld:pubmed
pubmed-article:17931663pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17931663pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17931663pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17931663pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17931663pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17931663pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17931663pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17931663pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17931663pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17931663pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17931663pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17931663pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17931663pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17931663pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17931663pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17931663pubmed:statusMEDLINElld:pubmed
pubmed-article:17931663pubmed:monthOctlld:pubmed
pubmed-article:17931663pubmed:issn0024-3205lld:pubmed
pubmed-article:17931663pubmed:authorpubmed-author:OhataHisayuki...lld:pubmed
pubmed-article:17931663pubmed:authorpubmed-author:HondaKazuoKlld:pubmed
pubmed-article:17931663pubmed:authorpubmed-author:MiyazakiTakur...lld:pubmed
pubmed-article:17931663pubmed:issnTypePrintlld:pubmed
pubmed-article:17931663pubmed:day27lld:pubmed
pubmed-article:17931663pubmed:volume81lld:pubmed
pubmed-article:17931663pubmed:ownerNLMlld:pubmed
pubmed-article:17931663pubmed:authorsCompleteYlld:pubmed
pubmed-article:17931663pubmed:pagination1421-30lld:pubmed
pubmed-article:17931663pubmed:dateRevised2009-11-19lld:pubmed
pubmed-article:17931663pubmed:meshHeadingpubmed-meshheading:17931663...lld:pubmed
pubmed-article:17931663pubmed:meshHeadingpubmed-meshheading:17931663...lld:pubmed
pubmed-article:17931663pubmed:meshHeadingpubmed-meshheading:17931663...lld:pubmed
pubmed-article:17931663pubmed:meshHeadingpubmed-meshheading:17931663...lld:pubmed
pubmed-article:17931663pubmed:meshHeadingpubmed-meshheading:17931663...lld:pubmed
pubmed-article:17931663pubmed:meshHeadingpubmed-meshheading:17931663...lld:pubmed
pubmed-article:17931663pubmed:meshHeadingpubmed-meshheading:17931663...lld:pubmed
pubmed-article:17931663pubmed:meshHeadingpubmed-meshheading:17931663...lld:pubmed
pubmed-article:17931663pubmed:meshHeadingpubmed-meshheading:17931663...lld:pubmed
pubmed-article:17931663pubmed:meshHeadingpubmed-meshheading:17931663...lld:pubmed
pubmed-article:17931663pubmed:meshHeadingpubmed-meshheading:17931663...lld:pubmed
pubmed-article:17931663pubmed:meshHeadingpubmed-meshheading:17931663...lld:pubmed
pubmed-article:17931663pubmed:meshHeadingpubmed-meshheading:17931663...lld:pubmed
pubmed-article:17931663pubmed:meshHeadingpubmed-meshheading:17931663...lld:pubmed
pubmed-article:17931663pubmed:meshHeadingpubmed-meshheading:17931663...lld:pubmed
pubmed-article:17931663pubmed:meshHeadingpubmed-meshheading:17931663...lld:pubmed
pubmed-article:17931663pubmed:meshHeadingpubmed-meshheading:17931663...lld:pubmed
pubmed-article:17931663pubmed:meshHeadingpubmed-meshheading:17931663...lld:pubmed
pubmed-article:17931663pubmed:meshHeadingpubmed-meshheading:17931663...lld:pubmed
pubmed-article:17931663pubmed:meshHeadingpubmed-meshheading:17931663...lld:pubmed
pubmed-article:17931663pubmed:meshHeadingpubmed-meshheading:17931663...lld:pubmed
pubmed-article:17931663pubmed:meshHeadingpubmed-meshheading:17931663...lld:pubmed
pubmed-article:17931663pubmed:meshHeadingpubmed-meshheading:17931663...lld:pubmed
pubmed-article:17931663pubmed:meshHeadingpubmed-meshheading:17931663...lld:pubmed
pubmed-article:17931663pubmed:meshHeadingpubmed-meshheading:17931663...lld:pubmed
pubmed-article:17931663pubmed:year2007lld:pubmed
pubmed-article:17931663pubmed:articleTitleModulation of Ca2+ transients in cultured endothelial cells in response to fluid flow through alphav integrin.lld:pubmed
pubmed-article:17931663pubmed:affiliationDepartment of Pharmacology, School of Pharmaceutical Sciences, Showa University, Hatanodai, Shinagawa-ku, Tokyo 142-8555, Japan. taku@pharm.showa-u.ac.jplld:pubmed
pubmed-article:17931663pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:17931663pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17931663lld:pubmed